Next Article in Journal
A Chart Review of Management of Ischemic Stroke Patients in Germany
Previous Article in Journal
Can We Well Assess the Relative Efficacy and Tolerability of a New Drug Versus Others at the Time of Marketing Authorization Using Mixed Treatment Comparisons? A Detailed Illustration with Escitalopram
 
 
Journal of Market Access & Health Policy (JMAHP) is published by MDPI from Volume 12 Issue 1 (2024). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Taylor & Francis.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Ischemic Stroke Management in West Scotland: A Chart Review

by
Patrice Verpillat
1,
Chantal Guilhaume-Goulant
2,
Julie Dorey
3,*,†,
Firas Dabbous
4 and
Samuel Aballéa
3
1
H. Lundbeck A/S, Paris, France
2
Laboratoire Santé- Individu-Société (SIS, E.A. 4129), University of Lyon 1, Lyon, France
3
Creativ-Ceutical, Paris, France
4
Division of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, IL, USA
*
Author to whom correspondence should be addressed.
Current address: US Operations, 53 W. Jackson Blvd, #735, Chicago, IL 60604, USA.
J. Mark. Access Health Policy 2015, 3(1), 26339; https://doi.org/10.3402/jmahp.v3.26339
Submission received: 16 October 2014 / Revised: 25 March 2015 / Accepted: 25 March 2015 / Published: 24 September 2015

Abstract

Background: Little information is available about the long-term management of ischemic stroke (IS) in West Scotland. In this study we aim to describe the management of IS at onset, admission, and during follow-up among patients who survived an IS event. Methods: General practitioners (GPs) (n = 20) were randomly selected to recruit IS patients and extract data about patient characteristics, hospitalizations, discharge, and ambulatory care from GP databases, hospital letters, and direct contact with patients and their relatives. Descriptive analyses were conducted. Results: One hundred and one patients were included, with a mean age of 65.6 ± 13.4. About half of the patients contacted their GPs at the time of onset (45.4%). Cardiovascular history was prevalent in 29.7% of cases, and 14% of all cases were recurrences. Of the patients, 89 (88%) were hospitalized with mean length of stay (LOS) 11.8 days. Treatment was administered on average within 12.9 hours of admission and 23.6% of the admitted patients received thrombolytic treatment. During the 1-year follow-up period, 33.6% of patients were rehospitalized and the mean LOS was 15.1 ± 29.5 days. Further, patients on average sought nursing care (10.9%), physical therapy (45.5%), occupational therapy (27.7%), speech therapy (12.9%), and professional caregivers (12%). Conclusion: The health-care resource utilization of IS patients is a major driver of economic burden.
Keywords: ischemic stroke; health-care resource utilization; thrombolysis; long-term management ischemic stroke; health-care resource utilization; thrombolysis; long-term management

Share and Cite

MDPI and ACS Style

Verpillat, P.; Guilhaume-Goulant, C.; Dorey, J.; Dabbous, F.; Aballéa, S. Ischemic Stroke Management in West Scotland: A Chart Review. J. Mark. Access Health Policy 2015, 3, 26339. https://doi.org/10.3402/jmahp.v3.26339

AMA Style

Verpillat P, Guilhaume-Goulant C, Dorey J, Dabbous F, Aballéa S. Ischemic Stroke Management in West Scotland: A Chart Review. Journal of Market Access & Health Policy. 2015; 3(1):26339. https://doi.org/10.3402/jmahp.v3.26339

Chicago/Turabian Style

Verpillat, Patrice, Chantal Guilhaume-Goulant, Julie Dorey, Firas Dabbous, and Samuel Aballéa. 2015. "Ischemic Stroke Management in West Scotland: A Chart Review" Journal of Market Access & Health Policy 3, no. 1: 26339. https://doi.org/10.3402/jmahp.v3.26339

APA Style

Verpillat, P., Guilhaume-Goulant, C., Dorey, J., Dabbous, F., & Aballéa, S. (2015). Ischemic Stroke Management in West Scotland: A Chart Review. Journal of Market Access & Health Policy, 3(1), 26339. https://doi.org/10.3402/jmahp.v3.26339

Article Metrics

Back to TopTop